A case of WHIM syndrome associated with diabetes and hypothyroidism

Pediatric Diabetes

Volumn 10, Issue 7, 2009, Pages 484-486

  Takaya, Junji ^a   Fujii, Yuri ^a   Higashino, Hirohiko ^a   Taniuchi, Shoichiro ^a   Nakamura, Makiko ^b   Kaneko, Kazunari ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Komatsu Hospital   (Japan)

Author keywords

Hypothyroidism; Myelokathexis; WHIM

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INSULIN; LEVOTHYROXINE; NUCLEOTIDE; THYROID HORMONE; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1; THYROXINE;

ALLELE; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHILD; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOLOGY; INFECTION; INSULIN TREATMENT; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOPENIA; MYELOKATHEXIS; NEUTROPENIA; NEWBORN SCREENING; NONSENSE MUTATION; PATHOGENESIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; THYROID HORMONE BLOOD LEVEL; VERRUCA VULGARIS; WHIM SYNDROME; BLOOD; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; NEWBORN; POLYURIA; STOP CODON; SYNDROME;

CHEMOKINE CXCL12; CHILD, PRESCHOOL; CODON, NONSENSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOTHYROIDISM; IMMUNE SYSTEM DISEASES; INFANT, NEWBORN; POLYURIA; RECEPTORS, CXCR4; SYNDROME; THYROID HORMONES; THYROXINE;

EID: 75549083748     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00503.x     Document Type: Article

References (11)

1. Gorlin RJ, Gelb B, Diaz GA, Lofsness KG, Pittelkow MR, Fenky JR. WHIM syndrome, an autosomal dominant disorder; clinical, hematological, and molecular studies. Am J Med Genet 2000, 91:368-376.
2. Hernandez PA, Gorlin RJ, Lukens JN. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003, 34:70-74.
3. Taniuchi S, Yamamoto A, Fujiwara T, Hasui M, Tsuji T, Kobayashi Y. Dizygotic twin sisters with myelokathexis: mechanism of its neutropenia. Am J Hematol 1999, 62:106-111.
4. Taniuchi S, Matsuda M, Fujii Y, Izawa K, Kanegane H, Kobayashi Y. The role of a mutation of the CXCR4 gene in WHIM syndrome. Hematologica 2005, 90:1271-1272.
5. Wetzler M, Talpaz M, Kellagher MJ, Gutterman JU, Kurzroch R. Myelokathexix: normalization of neutrophil counts and morphology by GM-CSF. JAMA 1992, 267:2179-2180.
6. Bohinjec J, Andoljsel D. Neutrophil-releasing activity of recombinant human granulocyte-macrophage colony stimulating factor in myelokathexis. Br J Haematol 1992, 82:169-170.
7. Lee MS, Chang I, Kim S. Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 2004, 83:82-92.
8. Yano T, Liu Z, Donovan J, Thomas MK, Habener JF. Stromal cell derived factor-1(SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes 2007, 56:2946-2957.
9. Aboumrad E, Madec AM, Thivolet C. The CXCR4/CXCL12 (SDF-1) signaling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol 2007, 148:432-439.
10. Yoon JW, Jun HS, Satamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 1998, 27:109-122.
11. Leng Q, Nie Y, Zou Y, Chen J. Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development. BMC Immunol 2008, 9:51.